Description: Humacyte Global, Inc pioneer in creating universally implantable, bioengineered tissues, aiming to revolutionize treatments and boost patient outcomes through innovative approaches. Call us!
Company Technology Pipeline Investors Support For Ukraine About Menu Toggle Publications Careers Contact Our Goal: Treat the Untreatable Humacyte is pioneering the development and manufacture of off-the-shelf, universally implantable bioengineered human tissues. The Humacyte Human Acellular Vessel (HAV) is a regenerative vascular conduit currently in various stages of clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and periph
We are committed to bringing first-in-class regenerative medicine products to the marketplace that will improve and save the lives of patients worldwide and transform the practice of medicine.
Privacy Policy
Energy stocks news and trading ideas
MIG.studio - Early Stage Incubator by Mulholland Investment Group
EssexBio
Ventures | Fresenius Medical Care
Universally Implantable Regenerative Human Tissues - Humacyte Global, Inc.